NREP
NEW REPRESENTATIVE AT IB RECEIVED
07/18/2025
Back to search
Official data from USPTO
AFFIDX
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
AFFIDX
ST13
US500000079304130Class
5, 9, 10, 44
Filing
79304130
Registration
6829613
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
45
Latest update
07/19/2025
Trademark type
Word
Nice classes
5, 9, 10, 44
Filing date
09/22/2020
Registration date
08/30/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/30/2022
Last transaction
07/19/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
GB
Examiner
OAKES, JEFFREY
Law office
O10
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Avacta Limited
Representatives
Christina M. Licursi Wolf Greenfield & Sacks, P.C.
Technical classification
Nice Classes
Class 5Class 9Class 10Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Diagnostic testing materialsnamely diagnostic kits consisting primarily of monoclonal antibodiesbuffersreagents for use in disease testingmedical diagnostic reagents and assays for testing of body fluidsdiagnostic agentspreparations and substances for medical purposes; diagnostic materials being diagnostic kits consisting primarily of monoclonal antibodiesbuffersreagents for use in disease testingmedical diagnostic reagents and assays for testing of body fluidsdiagnostic agentspreparations and substances for medical purposespreparations for medical testing purposes and test strips for medical testing purposes namely for testing for the detection and diagnosis of covid-19 and influenza; diagnostic materials being diagnostic kits consisting primarily of monoclonal antibodiesbuffersreagents for use in disease testingmedical diagnostic reagents and assays for testing of body fluidsdiagnostic agentspreparations and substances for medical purposespreparations for medical testing purposes and test strips for lateral flow medical testing purposes namely for the detection and diagnosis of covid-19 and influenza; diagnostic reagents for medical purposes; diagnostic testing materials being diagnostic kits consisting primarily of monoclonal antibodiesbuffersreagents for use in disease testingmedical diagnostic reagents and assays for testing of body fluidsdiagnostic agentspreparations and substances for medical purposes for the detection and diagnosis of covid-19 and influenza; diagnostic preparations for medical testing purposes; materials namely diagnostic kits consisting primarily of monoclonal antibodiesbuffersreagents for use in disease testingmedical diagnostic reagents and assays for testing of body fluidsdiagnostic agentspreparations and substances for medical purposesmedical diagnostic strips for lateral flow medical testing purposes namely for the detection and diagnosis of covid-19 and influenzadiagnostic reagents for medical testing purposesall for the detection and diagnosis of covid-19 and influenza
Class 9
Downloadable software in the nature of mobile application software for medical diagnostics; Downloadable software in the nature of mobile application software for the collectionanalysis and reporting of diagnostic tests; downloadable mobile application software for the collectionanalysis and reporting of diagnostic tests for Covid-19 and influenza
Class 10
Medical testing apparatusinstruments and equipment for diagnostic use namely apparatus for medical diagnostic testing for the detection and diagnosis of covid-19 and influenza; medical testing apparatusinstruments and equipment for the detection and diagnosis of Covid-19 and influenzanamely medical diagnostic apparatus for testing for virusesmedical diagnostic instruments for the analysis of body fluidsapparatus for virus testing purposes
Class 44
Medical diagnostic testing being medical testing for diagnostic or treatment purposesanalysis services namely medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical testing being medical testing for diagnostic or treatment purposesanalysis services namely medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical diagnostic testing being medical testing for diagnostic or treatment purposesanalysis services namely medical analysis services for diagnostic and treatment purposes provided by medical laboratories for covid-19 and influenza; medical testing being medical testing for diagnostic or treatment purposes and analysis services namely medical analysis services for diagnostic and treatment purposes provided by medical laboratories for covid-19 and influenza; advisory and information services relating to all the aforesaid
Publications
History of USPTO decisions and trademark events.
45 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/01/2025
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
07/01/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/01/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/01/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
07/01/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
07/01/2025
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
12/28/2022
FICS
FINAL DISPOSITION NOTICE SENT TO IB
12/07/2022
FIMP
FINAL DISPOSITION PROCESSED
12/07/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
11/30/2022
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
08/30/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
08/30/2022
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
08/01/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
07/13/2022
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
07/13/2022
GPNX
NOTIFICATION PROCESSED BY IB
07/05/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/14/2022
PUBO
PUBLISHED FOR OPPOSITION
06/14/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
06/08/2022
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
06/08/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/25/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/09/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/09/2022
GNRT
NON-FINAL ACTION E-MAILED
05/09/2022
CNRT
NON-FINAL ACTION WRITTEN
05/09/2022
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
05/02/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/18/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/18/2022
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
04/18/2022
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
08/31/2021
GNSL
LETTER OF SUSPENSION E-MAILED
08/31/2021
CNSL
SUSPENSION LETTER WRITTEN
08/31/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/04/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/04/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/04/2021
RFNT
REFUSAL PROCESSED BY IB
03/15/2021
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
02/22/2021
RFRR
REFUSAL PROCESSED BY MPU
02/22/2021
MAFR
APPLICATION FILING RECEIPT MAILED
02/16/2021
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
02/13/2021
CNRT
NON-FINAL ACTION WRITTEN
02/12/2021
DOCK
ASSIGNED TO EXAMINER
02/12/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/12/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
02/11/2021
Continuous trademark protection
Get notified about every new filing that threatens AFFIDX or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.